World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
48651
World Ranking
16862
National Ranking
8455

Overview

Joel E. Lavine is affiliated with Columbia University in the United States and has contributed extensively to medical research, particularly in the field of liver disease. Their research encompasses medicine broadly, with a focus on epidemiology, hepatology, endocrinology, diabetes and metabolism, physiology, and cardiology and cardiovascular medicine.

The primary topics covered in Joel E. Lavine's work include:

  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Diet and metabolism studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Diabetes and associated disorders
  • Lipid metabolism and disorders

Joel E. Lavine's notable recent publications include:

  • "Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH," 2020, published in Hepatology
  • "rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis," 2020, Journal of Hepatology
  • "Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges," 2020, Gastroenterology
  • "Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis," 2021, Science Translational Medicine
  • "Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice," 2020, Gastroenterology

Frequent collaborators in their research include:

  • Arun J. Sanyal
  • Rohit Loomba
  • Brent A. Neuschwander-Tetri
  • Claude B. Sirlin
  • Katherine P. Yates

The scientist's work appears in multiple academic venues, with the highest number of publications in "Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature." Other common publication venues include the Journal of Hepatology, Hepatology, Gastroenterology, and Science Translational Medicine.

Best Publications

  • The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Michael Charlton

  • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl

  • Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

    Arun J. Sanyal;Naga Chalasani;Kris V. Kowdley;Arthur McCullough

  • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Brent A Neuschwander-Tetri;Rohit Loomba;Arun J Sanyal;Joel E Lavine

  • The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl

  • Prevalence of Fatty Liver in Children and Adolescents

    Jeffrey B. Schwimmer;Reena Deutsch;Tanaz Kahen;Joel E. Lavine

  • Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial

    Joel E. Lavine;Jeffrey B. Schwimmer;Mark L. Van Natta;Jean P. Molleston;Jean P. Molleston

  • Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group

    Robert H. Squires;Benjamin L. Shneider;John Bucuvalas;Estella Alonso

  • Histopathology of pediatric nonalcoholic fatty liver disease.

    Jeffrey B. Schwimmer;Jeffrey B. Schwimmer;Cynthia Behling;Robert Newbury;Reena Deutsch

  • Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.

    Joel E. Lavine

  • Endpoints and clinical trial design for nonalcoholic steatohepatitis.

    Arun J. Sanyal;Elizabeth M. Brunt;David E. Kleiner;Kris V. Kowdley

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

    Jeffrey B Schwimmer;Reena Deutsch;Jeffrey B Rauch;Cynthia Behling

  • Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

    Brent A. Neuschwander-Tetri;Jeanne M. Clark;Nathan M. Bass;Mark L. Van Natta

  • Heritability of Nonalcoholic Fatty Liver Disease

    Jeffrey B. Schwimmer;Jeffrey B. Schwimmer;Manuel A. Celedon;Joel E. Lavine;Joel E. Lavine;Rany Salem

  • Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis

    An Tang;Justin Tan;Mark Sun;Gavin Hamilton

  • Fatty Liver: Imaging Patterns and Pitfalls

    Okka W Hamer;Diego A Aguirre;Giovanna Casola;Joel E Lavine

  • Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

    Rohit Loomba;Maria Abraham;Aynur Unalp;Laura Wilson

  • Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese Adolescents

    Jeffrey B. Schwimmer;Nancy McGreal;Reena Deutsch;Milton J. Finegold

  • Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

    Elizabeth M. Brunt;David E. Kleiner;Laura A. Wilson;Aynur Unalp

Frequent Co-Authors

Jeffrey B. Schwimmer
Jeffrey B. Schwimmer University of California, San Diego
Elizabeth M. Brunt
Elizabeth M. Brunt Washington University in St. Louis
Naga Chalasani
Naga Chalasani Indiana University
Rohit Loomba
Rohit Loomba University of California, San Diego
James Tonascia
James Tonascia Johns Hopkins University
Claude B. Sirlin
Claude B. Sirlin University of California, San Diego
David E. Kleiner
David E. Kleiner National Institutes of Health
Anna Mae Diehl
Anna Mae Diehl Duke University
Philip J. Rosenthal
Philip J. Rosenthal University of California, San Francisco
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in medicine in the USA, online education offers flexible options to build your credentials and expand your scope of practice. Many prospective students seek affordable pathways to become a nurse or advance into specialized roles, such as Family Nurse Practitioner. If you are exploring this route, there are numerous cheap online fnp programs that provide quality education and prepare you for national certification while being budget-friendly.

Entry-level nurses can benefit from the cheapest online nursing program options, which make it easier to earn your degree without excessive financial burden. For registered nurses aiming to further their qualifications, comparing rn to bsn online cost can help identify cost-effective ways to achieve a BSN and enhance career opportunities.

Nurses interested in research or academic careers should consider advancing their studies with online phd nursing programs. These programs are designed to be flexible for working professionals and support growth into leadership, teaching, or scholarly roles in health care.

Best Scientists Citing Joel E. Lavine

Trending Scientists